Nortech Systems Incorporated

NSYS Healthcare Medical Devices

In the quarter to June 2026, revenue grew 9.34%, EPS fell 8.33%, free cash flow fell 1,567.2% and total debt fell 79.0%, each against the same quarter a year earlier.

10.32 0.19 −1.81%
Market cap
$29.5M
P/E
27.9×
Fwd P/E
17.5×
Dividend yield
—
F-score
5/9
Altman Z
2.79
Beneish M
−2.62
Dividend safety
n/a

Insider Decisions trades per month

Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 61.50%

Capital & Financial Ratios $m

Market Cap 29.45
Revenue 124.65
Net Income 1.03
Free Cash Flow 2.95
Net Debt 0.93
Current Ratio 1.78 (at or above 1.5: strong)
Debt/Equity 0.07 (at or below 0.5: strong)
P/E ratio 27.89
Fwd P/E 17.50
P/S ratio 0.23
P/B ratio 0.82
Past 5Y EPS Growth —
This Y EPS Growth —
Next Y EPS Growth —
Next Y revenue growth 16.35% (at or above 10%: strong)
Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

P/E against its own 10 years 63.18%
10-year low 10-year high
P/S against its own 10 years 75.44%
10-year low 10-year high
P/B against its own 10 years 59.14%
10-year low 10-year high
EV/Sales against its own 10 years 56.16%
10-year low 10-year high
EV/FCF against its own 10 years 42.44%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2020 Powerpack
2019 Powerpack
2018 Powerpack
2017 Powerpack
special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 2 1 2 2
Receivables 19 15 17 20
Inventory 22 22 21 25
Other 14 14 15 17
59 55 56 64
2023 2024 2025 Q'26
Payables 16 12 13 15
ST’ Debt — — — 0
Other 4 5 5 7
27 21 30 36

Compound Annual Growth %

10y 5y 3y
Sales 0.27% 2.60% (4.08%)
Cash Flow (2.07%) 15.01% (20.22%)
Earnings 0.00% 0.00% 0.00%
Book Value 4.49% 13.04% 7.15%

Revenue $m

Mar Jun Sep Dec Year
’26 30 34 — — —
’25 27 31 30 30 118
’24 34 34 31 29 128
’23 35 35 33 36 139
’22 31 33 35 36 134
’21 22 30 29 33 115
’20 27 26 26 24 104
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (2) (1) — — —
’25 (3) 0 0 6 3
’24 3 (4) (2) 1 (2)
’23 2 (1) 2 0 2
’22 1 (3) 3 4 5
’21 (1) (5) 3 (2) (5)
’20 0 0 (1) 1 1
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (2) (1) — — —
’25 (3) 0 0 5 3
’24 2 (5) (2) 1 (4)
’23 1 (2) 2 (1) 0
’22 1 (4) 2 4 3
’21 (1) (5) 3 (2) (5)
’20 0 0 5 1 7
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 (0.01) 0.11 — — —
’25 (0.48) 0.12 (0.05) 0.31 (0.09)
’24 0.26 0.05 (0.27) (0.54) (0.47)
’23 0.23 0.22 0.42 1.51 2.38
’22 0.05 0.25 0.53 (0.14) 0.70
’21 (0.58) 0.06 1.24 1.76 2.54
’20 0.05 (0.05) 0.73 (1.33) (0.58)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 1.69 3.13 2.77 2.65 2.52 5.45 9.31 7.45 9.13 6.50

Analyst estimates 2026–2028

Powerpack
High 5.52 6.24 8.08 7.46 10.14 14.20 19.56 16.52 19.15 12.40
People
People Employees 904 800 819 784 699 807 832 775 744 713
Revenue/emp, $m 0.13 0.14 0.14 0.15 0.15 0.14 0.16 0.18 0.17 0.17
Income, $m
Income, $m Revenue 117 112 113 116 104 115 134 139 128 118
Gross margin, % 11.87 10.79 11.74 10.81 9.28 13.77 15.27 16.58 13.05 15.21
EBT 0 (2) 0 (1) (1) 8 3 5 (1) 0
EBT margin, % 0.07 (1.84) 0.43 (0.70) (1.19) 6.96 2.59 3.92 (0.73) 0.01
Net income 0 (2) 0 (1) (2) 7 2 7 (1) 0
Depreciation 2 3 2 2 5 2 2 2 2 1
Per share, $
Per share, $ Revenue 42.45 40.91 42.11 43.65 39.17 43.22 49.95 51.19 46.51 42.62
Earnings 0.02 (0.89) 0.06 (0.46) (0.58) 2.68 0.75 2.53 (0.47) (0.09)
Cash flow 1.29 0.29 0.91 0.37 0.51 (1.70) 2.01 0.65 (0.82) 0.99
Capex (0.71) (0.09) (0.52) (0.28) 2.07 (0.27) (0.90) (0.47) (0.46) (0.06)
Free cash flow 0.58 0.20 0.39 0.09 2.58 (1.98) 1.11 0.18 (1.28) 0.93
Book value 8.12 7.22 7.83 7.50 7.04 9.80 10.46 12.98 12.34 12.44
Shares, m 3 3 3 3 3 3 3 3 3 3
Valuation, ×
Valuation, × P/E 377.00 0.00 50.71 0.00 0.00 3.86 15.83 4.04 0.00 0.00
P/S 0.09 0.10 0.08 0.11 0.18 0.24 0.24 0.20 0.22 0.17
P/B 0.47 0.55 0.46 0.66 1.03 1.07 1.15 0.79 0.84 0.60
EV/Sales 0.20 0.22 0.20 0.24 0.26 0.32 0.29 0.24 0.29 0.18
EV/FCF 15.09 45.74 22.04 115.46 3.94 (7.00) 12.95 83.58 (10.50) 8.40
Cash, $m
Cash, $m Operating cash flow 4 1 2 1 1 (5) 5 2 (2) 3
Capex (2) 0 (1) (1) 6 (1) (2) (1) (1) 0
Free cash flow 2 1 1 0 7 (5) 3 0 (4) 3
Balance, $m
Balance, $m Working capital 19 20 21 21 22 29 28 32 34 26
Total debt 14 15 15 15 12 10 7 6 9 1
Net debt 14 14 14 15 8 8 5 4 8 (1)
Shareholders’ equity 22 20 21 20 19 26 28 35 34 35
Returns, %
Returns, % ROA 0.08 (4.55) 0.30 (2.02) (2.60) 11.47 2.94 9.50 (1.76) (0.35)
ROIC 1.11 (2.32) 2.25 0.41 (1.44) 4.21 7.36 9.37 (0.29) 1.82
ROE 0.20 (11.75) 0.82 (6.05) (8.10) 32.28 7.49 21.85 (3.76) (0.74)
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Nortech Systems Incorporated vs peers in Medical Devices (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
NNOX Nano-X Imaging Ltd. $38.6M — (loss-making) — (loss-making) +36.71% (above 0%: growing) n/m −21.37% (below 0%: shrinking) (1,050.87%) (1,334.91%) Compare
CVRX CVRx, Inc. $37.0M — (loss-making) — (loss-making) +15.57% (above 0%: growing) n/m −11.18% (below 0%: shrinking) 87.39% (82.92%) Compare
ELUT Elutia Inc. $34.9M 0.6× — (loss-making) −11.65% (below 0%: shrinking) n/m −2.52% (below 0%: shrinking) 59.62% (327.85%) Compare
QTI QT Imaging Holdings, Inc. $34.8M — (loss-making) — (loss-making) +103.20% (above 0%: growing) n/m −236.31% (below 0%: shrinking) 41.16% (25.07%) Compare
NSYS Nortech Systems Incorporated $29.5M 27.9× 17.5× +9.34% (above 0%: growing) −8.33% (below 0%: shrinking) −1,567.16% (below 0%: shrinking) 17.00% 1.86%
ITOC iTonic Holdings Ltd. $29.3M — — — — — — — Compare
PMI Flag Ship Acquisition Corp $23.4M 0.5× — (loss-making) +38.62% (above 0%: growing) n/m +46.79% (above 0%: growing) 20.85% (156.70%) Compare
NSPR InspireMD, Inc. $22.3M — (loss-making) — (loss-making) −0.39% (below 0%: shrinking) n/m −26.00% (below 0%: shrinking) (43.70%) (815.64%) Compare
ARAY Accuray Incorporated $20.8M — (loss-making) — (loss-making) −20.87% (below 0%: shrinking) n/m +117.83% (above 0%: growing) 35.22% 5.47% Compare
Median of peers $32.1M — — +15.57% — −11.18% 35.22% (156.70%)

All 149 Medical Devices stocks →

Nortech Systems Incorporated (NSYS) key facts

  • Nortech Systems Incorporated (NSYS) is a Medical Devices company in the Healthcare sector, listed on Nasdaq.
  • As of October 15, 2026, NSYS traded at $10.32, a market capitalization of $29.5 million.
  • Return on equity was −0.74% and debt-to-equity 0.07.
  • Its Piotroski F-score is 5 out of 9 and its Altman Z-score is 2.79 (grey zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Nortech Systems Incorporated (NSYS) Latest News

19 Aug

stockrow.com/NSYS · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com